Multicenter evaluation of a bilayer polymer blood collection tube for coagulation testing: Effect on routine hemostasis test results and on plasma levels of coagulation activation markers

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 8, 2006, Pages 625-631

  Toulon, Pierre ^a,e   Aillaud, Marie Françoise ^b   Arnoux, Dominique ^c   Boissier, Elodie ^d   Borg, Jeanne Yvonne ^d   Gourmel, Céline ^d  

^a Hôpital Cochin ^*  (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL NORD   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e University of Côte d'Azur   (France)

Author keywords

Anticoagulant treatment; Coagulation testing; Glass tubes; Polymer tubes

Indexed keywords

ANTICOAGULANT AGENT; BIOLOGICAL MARKER; CITRIC ACID; GLASS; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; POLYMER; THROMBOPLASTIN;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD CLOTTING TEST; BLOOD LEVEL; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EVALUATION; HEALTH CARE FACILITY; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SHELF LIFE; TUBE;

BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; BLOOD SPECIMEN COLLECTION; CITRATES; GLASS; HUMANS; MATERIALS TESTING; PLASTICS; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING;

EID: 33751036076     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000252595.79282.86     Document Type: Article

References (24)

1. Ernst DJ. Plastic collection tubes decrease risk of employee injury. Medical Laboratory Observer (Nokomis, FL). 2001; 33:44-46, 48, 50.
2. Postaire E. Les matières plastiques à usage pharmaceutique. Propriétés générales et biotechniques. 2nd ed. Paris: Editions Médicales Internationales; 1991.
3. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol 1997; 107:105-110.
4. Adcock DM, Kressin DC, Marlar RA. Minimum specimen volume requirements for routine coagulation testing: dependence on citrate concentration. Am J Clin Pathol 1998; 109:595-599.
5. ISO 6710 Geneva, Switzerland: 1995. Single-use containers for venous blood specimen collection. Version 1996-02. ISO Editions; 1996.
6. WHO. Guidelines for thromboplastin and plasma used to control oral anticoagulant therapy. WHO Tech Rep Ser 1999; 889:64-93.
7. nd revised edition of ECAT assay procedures. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1999. pp. 21-28.
8. Polack B, Schved J-F, Boneu , on behalf of the 'Groupe d'Etude sur l'Hémostase et la Thrombose' [GEHT]. Preanalytical recommendations of the 'Groupe d'Etude sur l'Hémostase et la Thrombose' (GEHT) for venous blood testing in hemostasis laboratories. Haemostasis 2001; 31:61-68.
9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; I:307-310.
10. Polack B, Vigier J-P. Stability of prothrombin time and the impact of container material [letter]. Clin Lab Haematol 2000; 22:58.
11. van den Besselaar AMHP, Meeuwisse-Braun J, Witteveen E, van Meegen E. Effect of evacuated blood collection tubes on thromboplastin calibration. Thromb Haemost 1998; 79:1062-1063.
12. van den Besselaar AMHP, Bertina RM, van der Meer FJM, den Hartigh J. Different sensitivities of various thromboplastins to two blood collection systems for monitoring oral anticoagulant therapy. Thromb Haemost 1999; 82:153-154.
13. van den Besselaar AMHP, Chantarangkul V, Tripodi A. A comparison of two sodium citrate concentrations in two evacuated blood collection systems for prothrombin time and ISI determination. Thromb Haemost 2000; 84:664-667.
14. D'Angelo G, Villa C. Measurement of prothrombin time in patients on oral anticoagulant therapy: effect of 2 different evacuated tubes [letter]. Haematologica 1999; 84:656-657.
15. Tripodi A, Chantarangkul V, Bressi C, Manucci PM. How to evaluate the influence of blood collection systems on the international sensitivity index. Protocol applied to two new evacuated tubes and eight coagulometer/ thromboplastin combinations. Thromb Res 2003; 108:85-89.
16. Biron-Andréani C, Mallol C, Séguret F, Schved J-F. Plastic versus siliconized glass tubes: evaluation in current laboratory practice [letter]. Thromb Haemost 2000; 83:800-801.
17. Flanders MM, Crist R, Rodgers GM. A comparison of blood collection in glass versus plastic vacutainers on results of esoteric coagulation assays. Lab Med 2003; 34:732-735.
18. Foucher K, Toulon P, Schved J-F, Polack B. Suggestions for an appropriate methodological approach for the validation of an evacuated blood collection tube made in plastic material including the effect of age. Thromb Haemost 2004; 91:945-947.
19. Gosselin RC, Janatpour K, Larkin EC, Lee YP, Owings JT. Comparison of samples obtained from 3.2% sodium citrate glass and two 3.2% sodium citrate plastic blood collection tubes used in coagulation testing. Am J Clin Pathol 2004; 122:843-848.
20. Heyns AD, van den Berg DJ, Kleynhans PH, du Toit PW. Unsuitability of evacuated tubes for monitoring heparin therapy by activated partial thromboplastin time. J Clin Pathol 1981; 34:63-68.
21. Toulon PA, Ajzenberg N, Motalib S. A new polymer sampling tube is suitable for coagulation testing in patients on antithrombotic therapy (heparin, LMWH and oral anticoagulant). Results of a multicenter evaluation [abstract]. Blood 2003; 102:121b.
22. Brill-Edwards P, Ginsberg JS, Johnston M, Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Intern Med 1993; 119:104-109.
23. Leroy-Matheron C, Gouault-Heilmann M. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1+2, thrombin-antithrombin complexes and D-dimers) measurements. Thromb Res 1994; 74:399-407.
24. Bauer KA, Barzegar S, Rosenberg RD. Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1+2 measurements. Thromb Res 1991; 63:617-628.